Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (1141-1150 of 9,628) with videos related to

Pageof 963
Sort By:
Leukemia|September 12, 2012
The addition of gemtuzumab ozogamicin to low-dose Ara-C improves remission rate but does not significantly prolong survival in older patients with acute myeloid leukaemia: results from the LRF AML14 and NCRI AML16 pick-a-winner comparisonA K Burnett, R K Hills, A E Hunter, et al.
Leukemia|January 1, 1990
Do chromosome abnormalities determine the type of acute leukemia that develops in CML?R Bernstein, R P Gale
Leukemia|September 5, 2012
IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomasN Gachard, M Parrens, I Soubeyran, et al.
Leukemia|September 6, 2012
EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocolsT Kalina, J Flores-Montero, V H J van der Velden, et al.
Leukemia|September 28, 2012
Bortezomib and dexamethasone consolidation following risk-adapted melphalan and stem cell transplantation for patients with newly diagnosed light-chain amyloidosisH Landau, H Hassoun, M A Rosenzweig, et al.
Leukemia|October 4, 2012
A pathway from leukemogenic oncogenes and stem cell chemokines to RNA processing via THOC5F Griaud, A Pierce, M B Gonzalez Sanchez, et al.
Leukemia|February 1, 1990
Molecular diversity of precursor B acute lymphoblastic leukemias identified by the immunoglobulin heavy chain gene organizationK Nakamura, M Sasaki, J Fujimoto, et al.
Leukemia|February 1, 1990
Cellular ara-CTP pharmacokinetics, response, and karyotype in newly diagnosed acute myelogenous leukemiaE H Estey, M J Keating, K B McCredie, et al.
Leukemia|October 20, 2012
Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1R Oostvogels, M C Minnema, M van Elk, et al.
Leukemia|August 1, 2012
Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cellsJ Etchin, Q Sun, A Kentsis, et al.
Pageof 963

Showing results (1141-1150 of 9,628) with videos related to

Sort By:
Pageof 963
Leukemia|September 12, 2012
The addition of gemtuzumab ozogamicin to low-dose Ara-C improves remission rate but does not significantly prolong survival in older patients with acute myeloid leukaemia: results from the LRF AML14 and NCRI AML16 pick-a-winner comparisonA K Burnett, R K Hills, A E Hunter, et al.
Leukemia|January 1, 1990
Do chromosome abnormalities determine the type of acute leukemia that develops in CML?R Bernstein, R P Gale
Leukemia|September 5, 2012
IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomasN Gachard, M Parrens, I Soubeyran, et al.
Leukemia|September 6, 2012
EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocolsT Kalina, J Flores-Montero, V H J van der Velden, et al.
Leukemia|September 28, 2012
Bortezomib and dexamethasone consolidation following risk-adapted melphalan and stem cell transplantation for patients with newly diagnosed light-chain amyloidosisH Landau, H Hassoun, M A Rosenzweig, et al.
Leukemia|October 4, 2012
A pathway from leukemogenic oncogenes and stem cell chemokines to RNA processing via THOC5F Griaud, A Pierce, M B Gonzalez Sanchez, et al.
Leukemia|February 1, 1990
Molecular diversity of precursor B acute lymphoblastic leukemias identified by the immunoglobulin heavy chain gene organizationK Nakamura, M Sasaki, J Fujimoto, et al.
Leukemia|February 1, 1990
Cellular ara-CTP pharmacokinetics, response, and karyotype in newly diagnosed acute myelogenous leukemiaE H Estey, M J Keating, K B McCredie, et al.
Leukemia|October 20, 2012
Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1R Oostvogels, M C Minnema, M van Elk, et al.
Leukemia|August 1, 2012
Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cellsJ Etchin, Q Sun, A Kentsis, et al.
Pageof 963